These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18039520)

  • 1. Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients.
    Murphy NF; O'Loughlin C; Ledwidge M; McCaffrey D; McDonald K
    Eur J Heart Fail; 2007 Dec; 9(12):1196-204. PubMed ID: 18039520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure.
    Valzania C; Gadler F; Eriksson MJ; Olsson A; Boriani G; Braunschweig F
    Eur J Heart Fail; 2007; 9(6-7):644-50. PubMed ID: 17347041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of heart failure and left ventricular systolic dysfunction after cardiac pacing in patients with preserved left ventricular systolic function.
    Kachboura S; Ben Halima A; Fersi I; Marrakchi S; Zouaoui W; Kammoun I
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):29-36. PubMed ID: 18062936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time intervals of cardiac resynchronization therapy in heart failure.
    Baker C; Love CJ; Moeschberger ML; Orsinelli DA; Yamokoski L; Leier CV
    Am J Cardiol; 2004 Nov; 94(9):1192-6. PubMed ID: 15518621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.
    Goldberg LR; Jessup M
    Circulation; 2006 Jun; 113(24):2851-60. PubMed ID: 16785351
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic changes before acute heart failure episodes in patients with advanced systolic left ventricular dysfunction.
    Ghio S; Serio A; Mangiavacchi M; Kjellström B; Valsecchi S; Vicini I; Campana C; Gasparini M; Gronda E; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):799-804. PubMed ID: 18607244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE).
    Kindermann M; Hennen B; Jung J; Geisel J; Böhm M; Fröhlig G
    J Am Coll Cardiol; 2006 May; 47(10):1927-37. PubMed ID: 16697307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of acute changes in left ventricular volume, systolic and diastolic functions, and intraventricular synchronicity after biventricular and right ventricular pacing for heart failure.
    Yu CM; Lin H; Fung WH; Zhang Q; Kong SL; Sanderson JE
    Am Heart J; 2003 May; 145(5):E18. PubMed ID: 12766742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brain natriuretic peptide (BNP) in coronary insufficiency: relationship with left ventricular filling and exercise tolerance].
    Logeart D; Gambert A; Beyne P; Guiti C; Geyer C; Bourgoin P; Alonso C; Ennezat PV; Gourgon R; Cohen-Solal A
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):523-8. PubMed ID: 12555377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effectiveness of dual site left ventricular cardiac resynchronization therapy in a patient with congestive heart failure.
    Sassara M; Achilli A; Bianchi S; Ficili S; Marullo A; Pontillo D; Achilli P; Peraldo C; Sgreccia F
    Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):805-7. PubMed ID: 15189538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
    Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
    J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R; Stuckenborg V; Löher A; Köbe J; Reinke F; Gunia S; Vahlhaus C; Breithardt G; Bruch C
    Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.
    Gasparini M; Regoli F; Ceriotti C; Galimberti P; Bragato R; De Vita S; Pini D; Andreuzzi B; Mangiavacchi M; Klersy C
    Am Heart J; 2008 Mar; 155(3):507-14. PubMed ID: 18294488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of right ventricular apex pacing on the Tei index and brain natriuretic peptide in patients with a dual-chamber pacemaker.
    Ichiki H; Oketani N; Hamasaki S; Ishida S; Kataoka T; Ogawa M; Saihara K; Okui H; Fukudome T; Shinasato T; Kubozono T; Ninomiya Y; Matsushita T; Otsuji Y; Tei C
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):985-90. PubMed ID: 16981923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of heart rate on mechanical dyssynchrony and left ventricular contractility in patients with heart failure and normal QRS duration.
    Kurita T; Onishi K; Dohi K; Tanabe M; Fujimoto N; Tanigawa T; Setsuda M; Isaka N; Nobori T; Ito M
    Eur J Heart Fail; 2007; 9(6-7):637-43. PubMed ID: 17467334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
    Fruhwald FM; Fahrleitner-Pammer A; Berger R; Leyva F; Freemantle N; Erdmann E; Gras D; Kappenberger L; Tavazzi L; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jul; 28(13):1592-7. PubMed ID: 17298973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.